Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
8887 | 1139 | 26.4 | 75% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2960 | 2178 | HAND FOOT SYNDROME//RADIATION RECALL//EXTRAVASATION |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | HAND FOOT SYNDROME | Author keyword | 56 | 58% | 6% | 64 |
2 | RADIATION RECALL | Author keyword | 42 | 83% | 2% | 24 |
3 | HAND FOOT SKIN REACTION | Author keyword | 27 | 66% | 2% | 25 |
4 | RADIATION RECALL DERMATITIS | Author keyword | 26 | 87% | 1% | 13 |
5 | NEUTROPHILIC ECCRINE HIDRADENITIS | Author keyword | 23 | 76% | 1% | 16 |
6 | PALMAR PLANTAR ERYTHRODYSESTHESIA | Author keyword | 19 | 64% | 2% | 18 |
7 | SERIES CLIN | Address | 12 | 75% | 1% | 9 |
8 | EPIDERMAL GROWTH FACTOR RECEPTOR INHIBITORS | Author keyword | 12 | 44% | 2% | 20 |
9 | PALMOPLANTAR ERYTHRODYSESTHESIA | Author keyword | 12 | 86% | 1% | 6 |
10 | EGFRI | Author keyword | 11 | 78% | 1% | 7 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | NEUTROPHILIC ECCRINE HIDRADENITIS | 33 | 66% | 3% | 31 |
2 | PALMAR PLANTAR ERYTHRODYSESTHESIA | 29 | 55% | 3% | 36 |
3 | DERMATOLOGICAL TOXICITIES | 28 | 81% | 1% | 17 |
4 | FACTOR RECEPTOR INHIBITORS | 28 | 41% | 5% | 53 |
5 | ACRAL ERYTHEMA | 22 | 66% | 2% | 21 |
6 | DRUG INDUCED COMA | 19 | 80% | 1% | 12 |
7 | INDUCED ACRAL ERYTHEMA | 17 | 59% | 2% | 19 |
8 | HAND FOOT SYNDROME | 17 | 44% | 3% | 29 |
9 | CUTANEOUS TOXICITIES | 16 | 54% | 2% | 20 |
10 | DISTINCTIVE ERUPTION | 12 | 86% | 1% | 6 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references |
% act. ref. to same field |
---|---|---|---|---|
Interdisciplinary management of EGFR-inhibitor-induced skin reactions: a German expert opinion | 2011 | 36 | 41 | 78% |
Nail toxicities induced by systemic anticancer treatments | 2015 | 1 | 47 | 68% |
Clinical practice guidelines for the prevention and treatment of EGFR inhibitor-associated dermatologic toxicities | 2011 | 58 | 79 | 35% |
Semiology of skin toxicity associated with epidermal growth factor receptor (EGFR) inhibitors | 2012 | 18 | 41 | 61% |
Skin toxicities associated with epidermal growth factor receptor inhibitors | 2009 | 96 | 62 | 42% |
Hand-Foot Syndrome (Hand-Foot Skin Reaction, Palmar-Plantar Erythrodysesthesia): Focus on Sorafenib and Sunitinib | 2009 | 60 | 68 | 60% |
Mechanisms of cutaneous toxicities to EGFR inhibitors | 2006 | 207 | 67 | 31% |
The hand-foot-syndrome associated with medical tumor therapy - classification and management | 2010 | 31 | 42 | 71% |
Dermatologic side effects associated with the epidermal growth factor receptor inhibitors | 2006 | 170 | 29 | 31% |
Imatinib, dasatinib and nilotinib: a review of adverse cutaneous reactions with emphasis on our clinical experience | 2013 | 12 | 65 | 38% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SERIES CLIN | 12 | 75% | 0.8% | 9 |
2 | HEPATOGASTROENTEROL GASTROINTESTINAL ONCOL | 3 | 100% | 0.3% | 3 |
3 | NW MEM FDN | 2 | 67% | 0.2% | 2 |
4 | CANC SKIN CARE PROGRAM | 1 | 100% | 0.2% | 2 |
5 | HUMAN HEREDITARY PATHOL DERMATOL | 1 | 50% | 0.2% | 2 |
6 | POLICLIN SAN MATTEO DERMATOL | 1 | 100% | 0.2% | 2 |
7 | BREAST CANC CLIN SECT | 1 | 50% | 0.1% | 1 |
8 | BUR C348 | 1 | 50% | 0.1% | 1 |
9 | CANC NEW S WALES | 1 | 50% | 0.1% | 1 |
10 | CENT DRUG S | 1 | 50% | 0.1% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000140692 | SHIITAKE DERMATITIS//FLAGELLATE DERMATITIS//FLAGELLATE ERYTHEMA |
2 | 0.0000119930 | SCALP COOLING//CHEMOTHERAPY INDUCED ALOPECIA//CHEMOTHERAPY INDUCED HAIR LOSS |
3 | 0.0000118620 | EXTRAVASATION//EXTRAVASATION INJURY//ANTHRACYCLINE EXTRAVASATION |
4 | 0.0000115149 | HYPERSENSITIVITY REACTIONS//HYPERSENSITIVITY REACTION//CARBOPLATIN HYPERSENSITIVITY |
5 | 0.0000079025 | RADIATION DERMATITIS//RADIODERMATITIS//MOIST DESQUAMATION |
6 | 0.0000064085 | YELLOW NAIL SYNDROME//NAIL PSORIASIS//NAIL PSORIASIS SEVERITY INDEX |
7 | 0.0000063583 | PANITUMUMAB//CETUXIMAB//METASTATIC COLORECTAL CANCER |
8 | 0.0000061697 | SUNITINIB//METASTATIC RENAL CELL CARCINOMA//CARCINOMA RENAL CELL |
9 | 0.0000055336 | HYDROXYUREA//GENET HUMAN THER Y//TARGET CELL AVAILABILITY |
10 | 0.0000054069 | NIMOTUZUMAB//H R3//CETUXIMAB |